Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...

PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Laser by Aleya, a provider of New York laser and electrolysis hair removal services, has announced a continued investment in personalized, education-driven skincare treatments aimed at empowering ...

Groundbreaking Harvard research reveals gut-produced molecules significantly influence obesity and blood sugar control. These ...

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...

MedPage Today brought together three hepatology experts for a virtual roundtable discussion on metabolic ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...